Theravance Biopharma press release ( TBPH ): Q4 net income was $61.0 million. Revenue of $45.9 million. Cash, cash equivalents and marketable securities totaled $326.5 million as of December 31, 2025. More on Theravance Biopharma Theravance drops rare disease drug after late-stage trial setback Seeking Alpha’s Quant Rating on Theravance Biopharma Historical earnings data for Theravance Biopharma F...
Theravance Biopharma press release ( TBPH ): Q4 net income was $61.0 million. Revenue of $45.9 million. Cash, cash equivalents and marketable securities totaled $326.5 million as of December 31, 2025. More on Theravance Biopharma Theravance drops rare disease drug after late-stage trial setback Seeking Alpha’s Quant Rating on Theravance Biopharma Historical earnings data for Theravance Biopharma Financial information for Theravance Biopharma
"Bloomberg ETF IQ" focuses on the opportunities, risks and current trends tied to the trillions of dollars in the global exchange traded funds industry. Today's guests: Strategas ETF Strategist Todd Sohn, JPMorgan Asset Management Head of US Equity Derivatives Hamilton Reiner, and BlackRock Head of Digital Assets Robert Mitchnick. (Source: Bloomberg)
"Bloomberg ETF IQ" focuses on the opportunities, risks and current trends tied to the trillions of dollars in the global exchange traded funds industry. Today's guests: Strategas ETF Strategist Todd Sohn, JPMorgan Asset Management Head of US Equity Derivatives Hamilton Reiner, and BlackRock Head of Digital Assets Robert Mitchnick. (Source: Bloomberg)
Broadcom (NASDAQ:AVGO) quietly crossed a significant threshold this week, shipping what it describes as the world’s first quantum-safe network encryption solution for enterprise infrastructure. For long-term AVGO shareholders, the timing and context of this launch deserve attention beyond the headline. What Is Quantum-Safe Encryption and Why Does It Matter Now Post-quantum cryptography (PQC) addre...
Broadcom (NASDAQ:AVGO) quietly crossed a significant threshold this week, shipping what it describes as the world’s first quantum-safe network encryption solution for enterprise infrastructure. For long-term AVGO shareholders, the timing and context of this launch deserve attention beyond the headline. What Is Quantum-Safe Encryption and Why Does It Matter Now Post-quantum cryptography (PQC) addresses a ... Broadcom Just Shipped the World’s First Quantum-Safe Network Encryption — 3 Reasons AVGO
Quick Read Broadcom (AVGO) shipped the world’s first quantum-safe network encryption solution embedded at the silicon level, positioning itself as first-mover in a compliance-driven enterprise upgrade cycle as regulators mandate post-quantum cryptography standards. The company reported Q1 FY2026 AI semiconductor revenue of $8.4B, up 106% year-over-year, with Q2 guidance at $10.7B, and Infrastructu...
Quick Read Broadcom (AVGO) shipped the world’s first quantum-safe network encryption solution embedded at the silicon level, positioning itself as first-mover in a compliance-driven enterprise upgrade cycle as regulators mandate post-quantum cryptography standards. The company reported Q1 FY2026 AI semiconductor revenue of $8.4B, up 106% year-over-year, with Q2 guidance at $10.7B, and Infrastructure Software revenue of $6.796B, creating a natural upsell opportunity through its VMware-powered enterprise relationships. Broadcom’s quantum-safe networking launch capitalizes on accelerating enterprise security spending tied to AI infrastructure buildout, while regulatory mandates for post-quantum cryptography create a compliance-driven refresh cycle that favors early entrants with hardware-level solutions. A recent study identified one single habit that doubled Americans’ retirement savings and moved retirement from dream, to reality. Read more here. Broadcom (NASDAQ:AVGO) quietly crossed a significant threshold this week, shipping what it describes as the world's first quantum-safe network encryption solution for enterprise infrastructure. For long-term AVGO shareholders, the timing and context of this launch deserve attention beyond the headline. What Is Quantum-Safe Encryption and Why Does It Matter Now Post-quantum cryptography (PQC) addresses a specific and growing threat: the "harvest now, decrypt later" attack strategy, where adversaries collect encrypted data today with the intent to decrypt it once quantum computers become powerful enough to break current encryption standards. For enterprises running sensitive workloads across cloud and private infrastructure, this is not a theoretical risk. It is an active data security concern that regulators and security teams are already responding to. Broadcom's milestone positions it as the first vendor to deliver PQC at the network silicon level, embedding quantum-safe encryption directly into networking hardware rather t...
Was it only at the new year that the fanfare was heard for the FTSE 100 index breaking through 10,000 for the first time? It was – on 2 January – and the index then added another 900 points by the end of February. On Thursday, the Footsie briefly fell below that round number as Iran struck Qatar’s enormous Ras Laffan complex, which normally supplies a fifth of the world’s liquefied natural gas, be...
Was it only at the new year that the fanfare was heard for the FTSE 100 index breaking through 10,000 for the first time? It was – on 2 January – and the index then added another 900 points by the end of February. On Thursday, the Footsie briefly fell below that round number as Iran struck Qatar’s enormous Ras Laffan complex, which normally supplies a fifth of the world’s liquefied natural gas, before closing at 10,063, down 2.3% on the day. There are two ways to view that price action. One is to say the sharp reversal from the peak represents a necessarily severe reaction to the war on Iran. Another is to conclude that a flat year-to-date return, after a bountiful 20% gain in 2025, suggests stock markets have barely begun to take seriously the inflationary impact if the war lasts many more weeks, or even months, and keeps oil above $100 a barrel. “Markets are very resilient and complacent, and we are a bit surprised about that,” said Nicolai Tangen, the head of Norway’s $2tn (£1.5tn) sovereign wealth fund, earlier this week. Well, quite. The resilience of companies themselves, as he suggested, is perhaps one explanation. Firms can cut costs and try to pass on increases in input prices. Recent shocks, such as the Covid pandemic and Russia’s invasion of Ukraine, may have forced them to inject greater flexibility into their supply chains. It is still far too early to hear profit warnings. In the case of the Footsie, a size-weighted index, there are also a few big constituents that obviously benefit from higher oil and gas prices: Shell and BP are up 24% and 31% respectively since the new year. Another explanation is that investors may be right – despite the strike on Ras Laffan – to keep the faith and believe that energy prices will calm down soon. That seems to be the consensus opinion. Bank of America’s closely watched regular poll of fund managers this week found that only 11% expect a barrel of Brent to be over $90 by the end of the year, and the average forecast...
Getty Images By Elior Manier Yesterday's FOMC meeting marked the beginning of a rough session for traders around the globe. Global stock indexes took large hits, correcting down 3% in Japan, London, and Europe and gapping down starkly in this morning's open. Dow Jones Index 4H chart – Source: TradingView As you can see on the index chart for the Dow Jones Industrial Index, heavy selling pressure f...
Getty Images By Elior Manier Yesterday's FOMC meeting marked the beginning of a rough session for traders around the globe. Global stock indexes took large hits, correcting down 3% in Japan, London, and Europe and gapping down starkly in this morning's open. Dow Jones Index 4H chart – Source: TradingView As you can see on the index chart for the Dow Jones Industrial Index, heavy selling pressure from a massive hawkish repricing has applied large pressure on US equities and others around the world. Yesterday's conference from Jerome Powell did not help to contain the initial scare of higher rates for longer – as a matter of fact, his wordings around the current 3.50%-3.75% were estimated to be located "at the plausible range of neutral [rates]", implying that further movement in the Fed policy would only be contingent on a weakening economy or labor market. And we haven't seen any sign of this for now – quite the contrary: jobless claims came at 205K, the lowest since January (and they were at two-year lows at that time) Jobless Claims since March 2023 – Source: Trading Economics This also combines with a flurry of central bank decisions (including the ECB, Bank of England, Bank of Japan and the Swiss National Bank), which haven't communicated any type of dovishness. When assuming that crude oil prices are now 40% higher than they were the last trading day of February and close to 90% higher since their January lows, it is difficult not to reprice some heavy form of inflation spike. Everybody feels it at the pump; it hasn't been fun. Market Reactions Crude oil spikes higher but eases since, Brent-WTI spread widens even more Brent to WTI Spread – Source: TradingView European and Asian markets are getting even more concerned by the latest escalation in energy infrastructure attacks across the Middle East, as these regions remain heavily affected by supply disruptions in the Strait of Hormuz. A detailed crude oil analysis will be coming at the top of the hour. US Treasu...
Entering 2026, silver looked unstoppable. It reached record highs in the early part of the year, but lately it's been a far different story. Investors have been piling into other assets, potentially looking to benefit from rising oil prices instead. As a result, the price of silver has been falling, and on Wednesday it fell below $70 per ounce, to levels it hasn't been at since late last year. The...
Entering 2026, silver looked unstoppable. It reached record highs in the early part of the year, but lately it's been a far different story. Investors have been piling into other assets, potentially looking to benefit from rising oil prices instead. As a result, the price of silver has been falling, and on Wednesday it fell below $70 per ounce, to levels it hasn't been at since late last year. The iShares Silver Trust (SLV 5.60%), which tracks the price of silver, has also been falling. It's trading around $64, down around 42% from its 52-week high of $109.83. Is now a good time to invest in silver, or could there be more pain to come for investors? Has the bubble burst for silver? The problem with silver is that these days, it's been trading more like a meme than a safe-haven investment. And that's why its price can go on such wild swings. While it's normally a much more stable investment, speculation has been playing a much larger role in its valuation of late, making it much riskier to invest in the iShares Silver Trust than usual. And these days, with oil prices spiking, investors and speculators appear to have moved on from silver stocks to the next hot theme: oil and gas. For example, the Energy Select Sector SPDR ETF has soared by 33% this year, while the S&P 500 has declined by around 4%. It does appear as though the bubble may be bursting for silver, and investors are pivoting to other opportunities. Expand NYSEMKT : SLV iShares Silver Trust Today's Change ( -5.60 %) $ -3.85 Current Price $ 64.85 Key Data Points Day's Range $ 60.86 - $ 65.13 52wk Range $ 26.57 - $ 109.83 Volume 6.3M Avg Vol 108M Should you invest in the iShares Silver Trust today? Although the iShares Silver Trust has been in a bit of a free fall of late, it has still more than doubled in value over the past year. While it may bounce back, there's also plenty of room for it to fall back down if there isn't a resurgence in the excitement around silver. Even if you're a risk-averse investor w...
Eli Lilly (LLY +0.08%) and Vertex Pharmaceuticals (VRTX +0.86%) have several things in common. Both are among the more prominent drugmakers in the world, and both have delivered market-beating returns over the past decade, although the larger Eli Lilly has performed much better on that front. Investors choosing between these two stocks can hardly go wrong, but which will be the better performer ov...
Eli Lilly (LLY +0.08%) and Vertex Pharmaceuticals (VRTX +0.86%) have several things in common. Both are among the more prominent drugmakers in the world, and both have delivered market-beating returns over the past decade, although the larger Eli Lilly has performed much better on that front. Investors choosing between these two stocks can hardly go wrong, but which will be the better performer over the next five to 10 years? Let's try to answer that question. The case for Eli Lilly Eli Lilly currently leads the rapidly growing weight-loss market. The company's tirzepatide, sold under the brand name Zepbound, is now the world's best-selling drug. Over the next two years, the pharmaceutical leader should add several weight loss products to its lineup. The company is gearing up to launch orforglipron, an oral GLP-1, which could earn the green light in the second quarter. The healthcare giant also posted strong phase 3 results for retatrutide, another promising weight-loss candidate, in December. Expand NYSE : LLY Eli Lilly Today's Change ( 0.08 %) $ 0.76 Current Price $ 918.81 Key Data Points Market Cap $867B Day's Range $ 911.00 - $ 924.53 52wk Range $ 623.78 - $ 1133.95 Volume 96K Avg Vol 3.1M Gross Margin 83.04 % Dividend Yield 0.68 % Meanwhile, Eli Lilly's newer approvals in other fields should also make headway, including Kisunla for Alzheimer's disease and Ebglyss for eczema. They won't be the company's main growth drivers, but they will help somewhat diversify its lineup. Lastly, Eli Lilly is looking to boost its already strong innovative engine by investing in artificial intelligence (AI). The company's lineup should drive top-line growth for the foreseeable future, while its AI initiatives help strengthen its moat. The case for Vertex Pharmaceuticals Vertex Pharmaceuticals generates strong sales and profits thanks to its medicines that treat the underlying causes of cystic fibrosis (CF), the only such drugs on the market. While this business remains strong, t...
Key Points The price of silver hit a record high earlier this year. The metal has been trading like a speculative meme investment over the past year, and it may remain volatile. Investors appear to be focusing more on oil and gas stocks these days. 10 stocks we like better than iShares Silver Trust › Entering 2026, silver looked unstoppable. It reached record highs in the early part of the year, b...
Key Points The price of silver hit a record high earlier this year. The metal has been trading like a speculative meme investment over the past year, and it may remain volatile. Investors appear to be focusing more on oil and gas stocks these days. 10 stocks we like better than iShares Silver Trust › Entering 2026, silver looked unstoppable. It reached record highs in the early part of the year, but lately it's been a far different story. Investors have been piling into other assets, potentially looking to benefit from rising oil prices instead. As a result, the price of silver has been falling, and on Wednesday it fell below $70 per ounce, to levels it hasn't been at since late last year. The iShares Silver Trust (NYSEMKT: SLV), which tracks the price of silver, has also been falling. It's trading around $64, down around 42% from its 52-week high of $109.83. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Is now a good time to invest in silver, or could there be more pain to come for investors? Has the bubble burst for silver? The problem with silver is that these days, it's been trading more like a meme than a safe-haven investment. And that's why its price can go on such wild swings. While it's normally a much more stable investment, speculation has been playing a much larger role in its valuation of late, making it much riskier to invest in the iShares Silver Trust than usual. And these days, with oil prices spiking, investors and speculators appear to have moved on from silver stocks to the next hot theme: oil and gas. For example, the Energy Select Sector SPDR ETF has soared by 33% this year, while the S&P 500 has declined by around 4%. It does appear as though the bubble may be bursting for silver, and investors are pivoting to other opportunities. Should you invest in the iShares Silver Tr...
Key Points Eli Lilly has strong momentum thanks to its leadership in the weight loss market. Vertex Pharmaceuticals' core franchise and newer approvals could drive top-line growth for a long time. One one of these drugmakers is performing better than the other on multiple fronts. 10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY) and Vertex Pharmaceuticals (NASDAQ: VRTX) have several ...
Key Points Eli Lilly has strong momentum thanks to its leadership in the weight loss market. Vertex Pharmaceuticals' core franchise and newer approvals could drive top-line growth for a long time. One one of these drugmakers is performing better than the other on multiple fronts. 10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY) and Vertex Pharmaceuticals (NASDAQ: VRTX) have several things in common. Both are among the more prominent drugmakers in the world, and both have delivered market-beating returns over the past decade, although the larger Eli Lilly has performed much better on that front. Investors choosing between these two stocks can hardly go wrong, but which will be the better performer over the next five to 10 years? Let's try to answer that question. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » The case for Eli Lilly Eli Lilly currently leads the rapidly growing weight-loss market. The company's tirzepatide, sold under the brand name Zepbound, is now the world's best-selling drug. Over the next two years, the pharmaceutical leader should add several weight loss products to its lineup. The company is gearing up to launch orforglipron, an oral GLP-1, which could earn the green light in the second quarter. The healthcare giant also posted strong phase 3 results for retatrutide, another promising weight-loss candidate, in December. Meanwhile, Eli Lilly's newer approvals in other fields should also make headway, including Kisunla for Alzheimer's disease and Ebglyss for eczema. They won't be the company's main growth drivers, but they will help somewhat diversify its lineup. Lastly, Eli Lilly is looking to boost its already strong innovative engine by investing in artificial intelligence (AI). The company's lineup should drive top-line growth for the foreseeable future, whi...
Key Points Analysts have been upgrading their price targets for Sandisk in recent months. The stock, however, has risen so much that the consensus average suggests it is overpriced. Much of the stock's future performance will hinge on demand remaining exceptionally strong. 10 stocks we like better than Sandisk › It's been over a year since memory and storage company Sandisk (NASDAQ: SNDK) spun off...
Key Points Analysts have been upgrading their price targets for Sandisk in recent months. The stock, however, has risen so much that the consensus average suggests it is overpriced. Much of the stock's future performance will hinge on demand remaining exceptionally strong. 10 stocks we like better than Sandisk › It's been over a year since memory and storage company Sandisk (NASDAQ: SNDK) spun off from Western Digital. And investors who have bought the stock, which focuses on flash memory storage, have enjoyed fantastic gains. If you were to invest just $1,000 into the stock a year ago, your investment would be worth more than $13,000 today, with its returns up over 1,200%. Sandisk has easily been one of the top tech stocks to own during the past year. Business has been booming due to strong growth for its products, and it now has a market cap of around $110 billion. But with the stock rallying so much so quickly, is it too late to invest in Sandisk, or can it still go higher? Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Here's how analysts think the stock will do A good way to gauge a stock's upside is to look at analyst price targets. While a stock is by no means a guarantee of hitting the consensus average, it can be a good indication of how much bullishness remains. These are, after all, people who cover the stock regularly. Currently, the consensus price target for SanDisk is around $570, which implies the stock could fall by about 23%. However, many analysts have also been raising their price targets recently, which often happens as a company does well and its financials look strong. And over the past couple of months, multiple analysts have set price targets of more than $800, with one as high as $1,000. There does look to be some upside that may be left for Sandisk, but that's only amon...
In this article BABA NVDA Follow your favorite stocks CREATE FREE ACCOUNT NVIDIA CEO Jensen Huang gestures during the NVIDIA GTC global AI conference in San Jose, California, U.S. March 17, 2026. Carlos Barria | Reuters Nvidia dominated the first era of AI -- CEO Jensen Huang is making sure it owns the next one. He's turning Nvidia from a chipmaker that's helping to drive a market cycle into the o...
In this article BABA NVDA Follow your favorite stocks CREATE FREE ACCOUNT NVIDIA CEO Jensen Huang gestures during the NVIDIA GTC global AI conference in San Jose, California, U.S. March 17, 2026. Carlos Barria | Reuters Nvidia dominated the first era of AI -- CEO Jensen Huang is making sure it owns the next one. He's turning Nvidia from a chipmaker that's helping to drive a market cycle into the operating system for the future of artificial intelligence. The shift has mostly gone unnoticed and hasn't yet been priced in by investors. But the clearest signal to date came this week. At Nvidia's annual developer conference, GTC , Huang launched NemoClaw, an open-source, chip-agnostic platform for building and deploying AI agents – autonomous software programs at the center of the latest advancements in the industry. "Every company in the world should have an agentic system strategy," Huang said. "This is the new computer now." New chip announcements got most of the attention at GTC, but the NemoClaw launch is the more important strategic shift and shows what Nvidia is actually becoming. Why the chipmaker model isn't enough Nvidia won the AI training era by locking in users. Its chips and software ecosystem became so deeply embedded in how AI models are built that switching to a competitor was nearly impossible. But the industry is shifting from building and training models to running them, and the inference workload doesn't require the same lock-in. Google , Amazon and Broadcom are all building their own inference-tailored chips. The moat that made Nvidia the most valuable company in the world is thinning. Selling chips, even the best chips, eventually means selling into a cycle. Owning the platform where those chips run is a more durable business. It's stickier, higher-margin, and harder to displace. That's where Huang is going on the offense with NemoClaw. The platform play NemoClaw is built on OpenClaw, an open-source agent created by a solo developer that went viral...
It would be funny if it wasn’t so Trumpy. Hosting the Japanese prime minister, Sanae Takaichi, in the Oval Office on Thursday, Donald Trump could not resist mocking Japan about its 1941 attack on Pearl Harbor during the second world war. After a series of questions about the current conflict in Iran, the US president was asked by a Japanese reporter: “Why didn’t you tell US allies in Europe and As...
It would be funny if it wasn’t so Trumpy. Hosting the Japanese prime minister, Sanae Takaichi, in the Oval Office on Thursday, Donald Trump could not resist mocking Japan about its 1941 attack on Pearl Harbor during the second world war. After a series of questions about the current conflict in Iran, the US president was asked by a Japanese reporter: “Why didn’t you tell US allies in Europe and Asia and Japan about the war before attacking Iran?” Trump replied: “One thing you don’t want to signal too much, you know, when we go in, we went in very hard and we didn’t tell anybody about it because we wanted surprise. Who knows better about surprise than Japan?” There was laughter in the room but the president had not finished. He asked mischievously: “Why didn’t you tell me about Pearl Harbor?” Suddenly the laughter died away. Takaichi’s eyes widened and she shifted in her chair as Trump evoked the moment that drew the US into the second world war. The Japanese attack on the US naval base in Pearl Harbor, Hawaii, took place on 7 December 1941, nearly five years before Trump was born. It killed 2,390 Americans and the US declared war on Japan the next day. Then president Franklin Delano Roosevelt called it “a date which will live in infamy”. The US defeated Japan in August 1945, days after atomic bomb attacks on Hiroshima and Nagasaki killed hundreds of thousands of civilians. Trump supporters relished his off-the-cuff response. His son Eric posted on the X social media platform: “One of the great responses to a reporter in history!” Critics were less impressed. Journalist Mehdi Hasan wrote: “I’m sorry, but this is legit hilarious. If only he wasn’t the president and just a character on TV. We could laugh our heads off without any sense of unease, dread, or embarrassment.” It was not Trump’s first awkward moment regarding the war. Last year, when Germany’s chancellor, Friedrich Merz, brought up 6 June as D-day, Trump responded that it was “not a pleasant day” for the ch...